Mormile, I.; Della Casa, F.; Petraroli, A.; Furno, A.; Granata, F.; Portella, G.; Rossi, F.W.; de Paulis, A.
Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus. Vaccines 2022, 10, 1221.
https://doi.org/10.3390/vaccines10081221
AMA Style
Mormile I, Della Casa F, Petraroli A, Furno A, Granata F, Portella G, Rossi FW, de Paulis A.
Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus. Vaccines. 2022; 10(8):1221.
https://doi.org/10.3390/vaccines10081221
Chicago/Turabian Style
Mormile, Ilaria, Francesca Della Casa, Angelica Petraroli, Alessandro Furno, Francescopaolo Granata, Giuseppe Portella, Francesca Wanda Rossi, and Amato de Paulis.
2022. "Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus" Vaccines 10, no. 8: 1221.
https://doi.org/10.3390/vaccines10081221
APA Style
Mormile, I., Della Casa, F., Petraroli, A., Furno, A., Granata, F., Portella, G., Rossi, F. W., & de Paulis, A.
(2022). Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus. Vaccines, 10(8), 1221.
https://doi.org/10.3390/vaccines10081221
